Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS)
Genes · 2023
DOI: 10.3390/genes14081581 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2023. Verfasst von Viktoriia Sofronova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Medicine and Human Genetics, North-Eastern Federal University, 677013 Yakutsk, Russia. Hauptthemen laut MEDLINE: Quality of Life, Mucopolysaccharidoses. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of the Russian Federation.
Abstract (Originalsprache)
Mucopolysaccharidosis-plus syndrome (MPSPS) is an autosomal-recessive disorder caused by c.1492C>T (p.R498W) in the VPS33A gene. MPSPS is a severe disorder that causes a short lifespan in patients. Currently, there is no specific treatment for patients. The Yakut population is more prone to this disease than others. Diagnosing MPSPS relies on clinical manifestations, and genetic testing (GT) is used to confirm the diagnosis. In this research, we examined two pregnancy cases, one of which involved a prenatal diagnosis for MPSPS. Notably, neither pregnant woman had a known family history of the disorder. During their pregnancies, both women underwent prenatal ultrasonography, which revealed increased prenasal thickness during the second trimester. In the first case, ultrasonography indicated increased prenasal thickness in the second trimester, but a definitive diagnosis was not made at that time. The patient was eventually diagnosed with MPSPS at 11 months of age. On the contrary, in the second case, GT uncovered that the parents were carriers of MPSPS. Consequently, a placental biopsy was performed, leading to an early diagnosis of MPSPS. This study emphasizes the importance of ultrasonography findings in prenatal MPSPS diagnosis. Combining ultrasonography with GT can be a valuable approach to confirming MPSPS at an early stage, allowing for the appropriate planning of delivery methods and medical care. Ultimately, this comprehensive approach can significantly enhance the quality of life of both affected patients and their parents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Molecular Medicine and Human Genetics, North-Eastern Federal University, 677013 Yakutsk, Russia.
- Department of Molecular and Genetic Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan.
- Medical Genetics Center, Republic Hospital No. 1-National Center of Medicine, 677019 Yakutsk, Russia.
ORCID-Profile: Viktoriia Sofronova, Takahito Moriwaki, Seigo Terawaki, Takanobu Otomo, Nadezhda Maksimova
Förderung
- Ministry of Education and Science of the Russian Federation
Zitieren
APA
Sofronova, V., Gotovtseva, L., Danilova, A., Sukhomyasova, A., Moriwaki, T., Terawaki, S., Otomo, T., & Maksimova, N. (2023). Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS). Genes. https://doi.org/10.3390/genes14081581
Vancouver
Sofronova V, Gotovtseva L, Danilova A, Sukhomyasova A, Moriwaki T, Terawaki S, et al. Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS). Genes. 2023. doi:10.3390/genes14081581
BibTeX
@article{Sofronova2023,
author = {Sofronova, Viktoriia and Gotovtseva, Lyutsiya and Danilova, Anastasia and Sukhomyasova, Aitalina and Moriwaki, Takahito and Terawaki, Seigo and Otomo, Takanobu and Maksimova, Nadezhda},
title = {Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS)},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14081581}
}
EUVIMED